EUVIMEDOdkrijte EUVIMED
Open access

COL6A2 drives clear cell renal cell carcinoma progression via integrin-dependent modulation of Wnt/β-catenin signaling

Xing Ji, Yongyang Yun, Zhenpeng Zhu, Tianyu Wu, Mingjian Ruan, Yu Fan, Qian Zhang

Journal of Cancer · 2025-11-14 · 16 (15) · 4426-4439

DOI: 10.7150/jca.120607 ↗

At a glance

Journal article in Journal of Cancer, published on 2025-11-14. Written by Xing Ji and 6 co-authors. Institution: Department of Urology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China. Cited 2 times so far (Crossref). The full text is freely available in PubMed Central.

PovzetekSubjectsBibliografski podatkiCiteRelated studies

Abstract (original language)

Povzetek ni na voljo.

Subjects

Author keywords

COL6A2Clear Cell Renal Cell CarcinomaEpithelial-Mesenchymal TransitionIntegrinPrognosisWnt/β-catenin signaling pathway

Authors and institutions

  • Department of Urology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.
  • Department of Urology, Peking University First Hospital, Beijing, 100034, China.
  • Institution of Urology, Peking University, Beijing, 100034, China.
  • National Urological Cancer Center, Beijing, 100034, China.
  • Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Beijing, 100034, China.

Cite

APA

Ji, X., Yun, Y., Zhu, Z., Wu, T., Ruan, M., Fan, Y., & Zhang, Q. (2025). COL6A2 drives clear cell renal cell carcinoma progression via integrin-dependent modulation of Wnt/β-catenin signaling. Journal of Cancer, 16(15), 4426-4439. https://doi.org/10.7150/jca.120607

Vancouver

Ji X, Yun Y, Zhu Z, Wu T, Ruan M, Fan Y, et al. COL6A2 drives clear cell renal cell carcinoma progression via integrin-dependent modulation of Wnt/β-catenin signaling. Journal of Cancer. 2025;16(15):4426-4439. doi:10.7150/jca.120607

BibTeX
@article{Ji2025,
  author = {Ji, Xing and Yun, Yongyang and Zhu, Zhenpeng and Wu, Tianyu and Ruan, Mingjian and Fan, Yu and Zhang, Qian},
  title = {COL6A2 drives clear cell renal cell carcinoma progression via integrin-dependent modulation of Wnt/β-catenin signaling},
  journal = {Journal of Cancer},
  year = {2025},
  volume = {16},
  number = {15},
  pages = {4426--4439},
  doi = {10.7150/jca.120607}
}
Start for free →